![Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio](https://journals.asm.org/cms/10.1128/mbio.00099-22/asset/d53f4c66-5cbf-43e6-8637-293791c4d556/assets/images/medium/mbio.00099-22-f002.gif)
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio
![PDF) Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion PDF) Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion](https://i1.rgstatic.net/publication/359149795_Characterization_of_SARS-CoV-2_Variants_B16171_Kappa_B16172_Delta_and_B1618_by_Cell_Entry_and_Immune_Evasion/links/633ec791ff870c55ce067fdd/largepreview.png)
PDF) Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion
![Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio](https://journals.asm.org/cms/10.1128/mbio.00099-22/asset/436f63da-2f4b-48a5-8830-b18e77712537/assets/images/medium/mbio.00099-22-f003.gif)
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio
![Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio](https://journals.asm.org/cms/10.1128/mbio.00099-22/asset/a7766e03-a7de-4b96-8650-7df27b7b01a7/assets/images/medium/mbio.00099-22-f004.gif)
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio
![Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio](https://journals.asm.org/cms/10.1128/mbio.00099-22/asset/b140a2f8-a95f-48eb-9908-cd35b975559e/assets/images/medium/mbio.00099-22-f001.gif)
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio
![Vaccination with Span, an antigen guided by SARS-CoV-2 S protein evolution, protects against challenge with viral variants in mice | Science Translational Medicine Vaccination with Span, an antigen guided by SARS-CoV-2 S protein evolution, protects against challenge with viral variants in mice | Science Translational Medicine](https://www.science.org/cms/asset/964265b4-a86e-4c6c-a62c-29d0d814128f/keyimage.gif)
Vaccination with Span, an antigen guided by SARS-CoV-2 S protein evolution, protects against challenge with viral variants in mice | Science Translational Medicine
![RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer | Cell Death & Differentiation RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer | Cell Death & Differentiation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41418-019-0379-5/MediaObjects/41418_2019_379_Fig1a_HTML.png)
RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer | Cell Death & Differentiation
![Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion | mBio](https://journals.asm.org/cms/10.1128/mbio.00099-22/asset/c355a0b9-458b-4bbe-880e-f48e46e35db6/assets/images/medium/mbio.00099-22-f005.gif)